PTC Therapeutics Inc
XBER:BH3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
P
|
PTC Therapeutics Inc
XBER:BH3
|
US |
|
JCDecaux SE
F:DCS0
|
FR |
|
G
|
General Mills Inc
XMUN:GRM
|
US |
|
K
|
KGHM Polska Miedz SA
F:KGHA
|
PL |
|
E
|
Electronic Arts Inc
XBER:ERT
|
US |
|
T
|
TriNet Group Inc
SWB:TN3
|
US |
|
B
|
Barclays PLC
XHAM:BCY
|
UK |
|
N
|
NEC Corp
F:NEC1
|
JP |
|
O
|
OMS Energy Technologies Inc
NASDAQ:OMSE
|
SG |
|
P
|
Procter & Gamble Co
XETRA:PRG
|
US |
|
Kenedix Office Investment Corp
F:K9R
|
JP |
|
P
|
Perpetua Resources Corp
NASDAQ:PPTA
|
US |
|
Meituan
HKEX:3690
|
CN |
|
Sociedad Quimica y Minera de Chile SA
NYSE:SQM
|
CL |
|
F
|
First Advantage Corp
F:0MS
|
US |
|
3
|
3i Group PLC
XBER:IGQ5
|
UK |
|
U
|
UniCredit SpA
XBER:CRIN
|
IT |
|
Melco Resorts & Entertainment Ltd
NASDAQ:MLCO
|
HK |
|
L
|
LK Technology Holdings Ltd
XBER:L5D
|
HK |
|
Investec Ltd
OTC:ITCFY
|
ZA |
Bankruptcy Probability
PTC Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
PTC Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
PTC Therapeutics Inc
NASDAQ:PTCT
|
6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| FR |
|
Pharnext SCA
OTC:PNEXF
|
6T USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Abbvie Inc
NYSE:ABBV
|
356.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
179.1B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
163B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
E
|
Epizyme Inc
F:EPE
|
94.1B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
109.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
75.6B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
41.5B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
S
|
Seagen Inc
F:SGT
|
39.3B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
57.8B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
PTC Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, PTC Therapeutics Inc has total debt of 2B USD. This includes both short-term (0 USD) and long-term (2B USD) debt.
You can find a full breakdown on its Balance Sheet.
